{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T10:52:22Z","timestamp":1749120742527,"version":"3.38.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019871","name":"Castle Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jdin.2024.03.019","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:08:57Z","timestamp":1712441337000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey"],"prefix":"10.1016","volume":"16","author":[{"given":"Nicholas D.","family":"Brownstone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Farberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9530-3383","authenticated-orcid":false,"given":"Graham H.","family":"Litchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann P.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka V.","family":"Hurton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Lio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2024.03.019_bib1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.019_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.jdin.2024.03.019_bib3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.jdin.2024.03.019_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.jdin.2024.03.019_bib5","first-page":"504","article-title":"The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives","volume":"9","author":"Feldman","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.019_bib6","first-page":"479","article-title":"Health care utilization and cost associated with biologic treatment patterns among patients with moderate to severe psoriasis: analyses from a large U.S. Claims database","volume":"25","author":"Feldman","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.019_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2176708","article-title":"Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies","volume":"34","author":"Thai","year":"2023","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jdin.2024.03.019_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.875492","article-title":"Unmet medical needs in chronic, non-communicable inflammatory skin diseases","volume":"9","author":"Ujiie","year":"2022","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.019_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s40257-020-00533-z","article-title":"Progress to date in advancing stratified medicine in psoriasis","volume":"21","author":"Reid","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.019_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2024.03.019_bib11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdv.13611","article-title":"Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","volume":"30","author":"Menter","year":"2016","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.jdin.2024.03.019_bib12","article-title":"Mechanism of action matters: a review of new and emerging biologics","author":"Cohen","year":"2019","journal-title":"Pract Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.019_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamadermatol.2018.0183","article-title":"Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR","volume":"154","author":"Mason","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.019_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/br.2017.922","article-title":"Personalized medicine could transform healthcare","volume":"7","author":"Mathur","year":"2017","journal-title":"Biomed Rep"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.019_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.21037\/tcr-21-1920","article-title":"A narrative review of five multigenetic assays in breast cancer","volume":"11","author":"Zeng","year":"2022","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jdin.2024.03.019_bib16","article-title":"Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: an international guidelines-based approach","volume":"26","author":"Turner","year":"2021","journal-title":"Hum Pathol Rep"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.019_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13555-022-00709-x","article-title":"Expert consensus on the use of prognostic gene expression profiling tests for the management of cutaneous melanoma: consensus from the skin cancer prevention working group","volume":"12","author":"Farberg","year":"2022","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jdin.2024.03.019_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00403-022-02344-0","article-title":"A cross-sectional analysis of trends in dermatology practice size in\u00a0the United States from 2012 to 2020","volume":"315","author":"Parthasarathy","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.019_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jaad.2021.03.123","article-title":"Characterization of the active Medicare dermatology workforce","volume":"86","author":"Murphy","year":"2022","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T03:59:31Z","timestamp":1740887971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":19,"alternative-id":["S2666328724000610"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.03.019","relation":{},"ISSN":["2666-3287"],"issn-type":[{"type":"print","value":"2666-3287"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}